Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Capital/Financing Update 2018

Oct 5, 2018

61842_rns_2018-10-05_3dacbe07-5cdb-41a5-a245-75fcf4f0c07c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [43 x 41] intentionally omitted <==

==> picture [106 x 24] intentionally omitted <==

==> picture [408 x 46] intentionally omitted <==

==> picture [94 x 55] intentionally omitted <==

CONFIDENTIAL

SOAPSL/207921/BLR/091801366 September 29, 2018

Mr. Hariharan S

Executive Director & Chief Financial Officer Solara Active Pharma Sciences Limited No 28 3rd and 4th Floor Batra Centre Sardar Patel Road Chennai - 600032 Tel:

Dear Mr. Hariharan S,

Re: Assignment of CRISIL Ratings to the bank facilities of Solara Active Pharma Sciences Limited

All ratings assigned by CRISIL are kept under continuous surveillance and review.

Please find in the table below the ratings outstanding for the debt instruments/facilities of the company, and the rating actions by CRISIL on the ratings as on date.

rating actions by CRISIL on the ratings as on date.
Total Bank Loan Facilities Rated Rs.1165 Crore
Long-Term Rating CRISIL BBB+/Stable (Assigned)
Short-Term Rating CRISIL A2 (Assigned)

(Bank-wise details as per Annexure 1)

As per our Rating Agreement, CRISIL would disseminate the ratings, along with the outlook, through its publications and other media, and keep the ratings, along with the outlook, under surveillance over the life of the instrument/facility. CRISIL reserves the right to withdraw, or revise the ratings, along with the outlook, at any time, on the basis of new information, or unavailability of information, or other circumstances which CRISIL believes may have an impact on the ratings.

In the event of the company not availing the proposed facilities within a period of 180 days from the date of this letter, a fresh letter of revalidation from CRISIL will be necessary.

This letter will remain valid till November 23, 2019. After this date, please insist for a new rating letter (dated later than November 23, 2019). Please visit www.crisil.com to confirm that the rating continues to be under surveillance and the rating is still valid.

Should you require any clarifications, please feel free to get in touch with us.

With warm regards,

Yours sincerely,

==> picture [120 x 31] intentionally omitted <==

Nitin Kansal Director - CRISIL Ratings

==> picture [121 x 31] intentionally omitted <==

Nivedita Shibu Associate Director - CRISIL Ratings

==> picture [54 x 54] intentionally omitted <==

A CRISIL rating reflects CRISIL's current opinion on the likelihood of timely payment of the obligations under the rated instrument and does not constitute an audit of the rated entity by CRISIL. CRISIL ratings are based on information provided by the issuer or obtained by CRISIL from sources it considers reliable. CRISIL does not guarantee the completeness or accuracy of the information on which the rating is based. A CRISIL rating is not a recommendation to buy, sell, or hold the rated instrument; it does not comment on the market price or suitability for a particular investor. All CRISIL ratings are under surveillance. Ratings are revised as and when circumstances so warrant. CRISIL is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of this product. CRISIL Ratings rating criteria are available without charge to the public on the CRISIL web site, www.crisil.com. For the latest rating information on any instrument of any company rated by CRISIL, please contact Customer Service Helpdesk at 1800267-1301.

CRISIL Limited

Corporate Identity Number: L67120MH1987PLC042363


Registered Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai- 400 076. Phone: +91 22 3342 3000 | Fax: +91 22 4040 5800 www.crisil.com

Annexure 1 - Bank-wise details of various facility classes (outstanding facilities)

S.No. Bank Facility Bank Amount (Rs. in Crore) Outstanding Rating
1 Cash Credit IDFC Bank Limited 25.0 CRISIL BBB+/Stable
2 Cash Term Loan RBL Bank Limited 12.9 CRISIL BBB+/Stable
3 Cash Term Loan YES Bank Limited 125.0 CRISIL BBB+/Stable
4 Cash Term Loan Aditya Birla FinanceLimited 85.0 CRISIL BBB+/Stable
5 Cash Term Loan IDFC Bank Limited 135.0 CRISIL BBB+/Stable
Export Packing Credit &
6 Export BillsNegotiation/Foreign Bill Axis Bank Limited 10.4 CRISIL A2
discounting
Export Packing Credit &
7 Export BillsNegotiation/Foreign Bill RBL Bank Limited 271.0 CRISIL A2
discounting
Export Packing Credit &
8 Export BillsNegotiation/Foreign Bill YES Bank Limited 50.0 CRISIL A2
discounting
9 Import Letter of CreditLimit YES Bank Limited 50.0 CRISIL A2
10 Inland/Import Letter ofCredit RBL Bank Limited 119.0 CRISIL A2
11 Proposed Long TermBank Loan Facility Proposed 281.7 CRISIL BBB+/Stable
Total 1165.0

A CRISIL rating reflects CRISIL's current opinion on the likelihood of timely payment of the obligations under the rated instrument and does not constitute an audit of the rated entity by CRISIL. CRISIL ratings are based on information provided by the issuer or obtained by CRISIL from sources it considers reliable. CRISIL does not guarantee the completeness or accuracy of the information on which the rating is based. A CRISIL rating is not a recommendation to buy, sell, or hold the rated instrument; it does not comment on the market price or suitability for a particular investor. All CRISIL ratings are under surveillance. Ratings are revised as and when circumstances so warrant. CRISIL is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of this product. CRISIL Ratings rating criteria are available without charge to the public on the CRISIL web site, www.crisil.com. For the latest rating information on any instrument of any company rated by CRISIL, please contact Customer Service Helpdesk at 1800267-1301.

CRISIL Limited

Corporate Identity Number: L67120MH1987PLC042363


Registered Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai- 400 076. Phone: +91 22 3342 3000 | Fax: +91 22 4040 5800 www.crisil.com